Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...
Saved in:
| Main Authors: | Andy Liu, Huda Alalami, Xuemo Fan, Chirag Patil, Jaya M Gill, Santosh Kesari, Jethro Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-09-01
|
| Series: | CNS Oncology |
| Subjects: | |
| Online Access: | https://www.futuremedicine.com/doi/10.2217/cns-2022-0021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Therapies in Primary Central Nervous System Lymphoma
by: Wakim M, et al.
Published: (2025-05-01) -
Antiepileptic drugs failed to prevent initial seizures or improve survival outcomes in patients with primary CNS lymphoma
by: Mengxue Zhang, et al.
Published: (2025-03-01) -
Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma
by: Zhongqing Zou, et al.
Published: (2025-07-01) -
Correction: Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma
by: Zhongqing Zou, et al.
Published: (2025-08-01) -
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
by: Avinash Vijaykumar Pandey, et al.
Published: (2015-01-01)